PFRM3 · PROFARMA DISTRIB PROD FARMACEUTICOS S.A. · Financials
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
11.45B
+12.8%
FY2025
Net Income
118.9M
+3.8%
FY2025
Gross Margin
15.29%
+0.3pp
FY2025
Operating Cash Flow
459.72M
-7.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRL | 13.5B | 11.45B | 10.15B | 8.66B | 7.82B | 6.41B | 5.48B | 4.8B | 4.27B | 4.1B | 4.08B | 3.47B | 3.45B | 3.47B | 3.8B | 3.32B | 3.13B |
| BRL | 11.49B | 9.7B | 8.63B | 7.37B | 6.67B | 5.51B | 4.72B | 4.06B | 3.59B | 3.4B | 3.46B | 3.03B | 3.02B | 3.16B | 3.6B | 3.15B | 2.95B |
| BRL | 2.02B | 1.75B | 1.52B | 1.29B | 1.15B | 907.57M | 763.57M | 737.84M | 680.91M | 700.97M | 625.25M | 436.97M | 431.97M | 307.48M | 204.74M | 163.68M | 181.14M |
| BRL | 188.43M | 117.46M | 127.86M | 81.59M | 78.97M | 48.75M | 33.15M | 21.56M | -30.13M | -153.61M | -52.42M | -19.82M | -60.63M | 19.96M | 55.77M | 31.59M | 40.03M |
| BRL | 30.11M | -8.55M | 5.05M | 3.74M | -6.07M | -30.37M | -28.65M | 9.58M | -20.4M | -40.89M | -3.46M | 1.36M | -8.25M | 896K | 13.49M | 4.4M | 5.64M |
| BRL | 151.81M | 118.9M | 114.58M | 70.4M | 80.87M | 78.19M | 52.33M | 11.98M | -9.73M | -112.72M | -48.96M | -21.18M | -52.12M | 20.35M | 40.59M | 26.42M | 34.38M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.